Heuron
PrivateLast Round
Series D
Dec 1, 2024
Est. Valuation
$178.23M
Total Funding Raised
$32.14M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Heuron operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Series D round in December 2024.
Heuron is a healthcare technology company that provides AI-based diagnostic aid solutions for central nervous system diseases, including Alzheimer's, Parkinson's, and stroke.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Imaging, Medical Devices, Computer Vision
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Heuron Comparables
Compare Heuron with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Brainomix | 86% | |
| JLK Inc. | 84% | |
| RapidAI | 83% |
For institutional investors. Book with your work email.
Heuron Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Dec 1, 2024 | ||||
| Series C | May 1, 2021 | ||||
| Series B | Jul 22, 2020 | ||||
| Series A | Jul 4, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Heuron Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Smilegate Investment | Series B |
| Korea Investment Partners | Series B |
| LogInvestment | Series C |
| Korea Growth Investment Corporation | Series C |
| HB Investment | Series C, Series B, Series D |
| We Ventures | Series B |
| Korea Investment & Securities | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 186% MoM.
- Apr 17, 2025
Attended the 2025 Korean Emergency Medicine Academic Conference in Gwangju.
For institutional investors. Book with your work email.
Heuron Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Heuron's valuation, stock price, and market status.
Is Heuron a public or private company?
Heuron is a private company.
What is the current stock price of Heuron?
Heuron is a private company, so its shares have no public market price. Caplight tracks Heuron's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Heuron worth (valuation)?
Heuron's valuation is estimated at $178.2M based on funding round data.
Can I buy Heuron stock?
Heuron shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Heuron's last funding round?
Heuron's most recent funding round was Series D on December 1, 2024.
Who are the main investors in Heuron?
Key investors in Heuron include HB Investment, AJU IB Investment, Solasta Ventures.
Will Heuron IPO soon?
No public IPO plans have been announced for Heuron.
How can I track Heuron secondary market activity?
Caplight tracks bids, offers, and trades in Heuron's shares on secondary markets.